IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
176.34
+10.72 (6.47%)
May 28, 2026, 11:09 AM EDT - Market open
IQVIA Holdings Employees
IQVIA Holdings had 93,000 employees as of December 31, 2025. The number of employees increased by 5,000 or 5.68% compared to the previous year.
Employees
93,000
Change (1Y)
5,000
Growth (1Y)
5.68%
Revenue / Employee
$178,839
Profits / Employee
$14,892
Market Cap
29.43B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 93,000 | 5,000 | 5.68% |
| Dec 31, 2024 | 88,000 | 1,000 | 1.15% |
| Dec 31, 2023 | 87,000 | 1,000 | 1.16% |
| Dec 31, 2022 | 86,000 | 7,000 | 8.86% |
| Dec 31, 2021 | 79,000 | 9,000 | 12.86% |
| Dec 31, 2020 | 70,000 | 3,000 | 4.48% |
| Dec 31, 2019 | 67,000 | 9,000 | 15.52% |
| Dec 31, 2018 | 58,000 | 3,000 | 5.45% |
| Dec 31, 2017 | 55,000 | 5,000 | 10.00% |
| Dec 31, 2016 | 50,000 | 13,900 | 38.50% |
| Dec 31, 2015 | 36,100 | 3,500 | 10.74% |
| Dec 31, 2014 | 32,600 | 4,400 | 15.60% |
| Dec 31, 2013 | 28,200 | 788 | 2.87% |
| Dec 31, 2012 | 27,412 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Labcorp Holdings | 71,000 |
| Quest Diagnostics | 57,000 |
| Agilent Technologies | 18,100 |
| Mettler-Toledo International | 18,100 |
| IDEXX Laboratories | 11,000 |
| Revvity | 11,000 |
| Illumina | 10,080 |
| Waters | 7,900 |
IQV News
- 1 day ago - IQVIA CEO to Speak at Jefferies Global Healthcare Conference - Business Wire
- 14 days ago - Iqvia, Kexing expand strategic collaboration - TheFly
- 14 days ago - IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities - Business Wire
- 14 days ago - IQVIA Holdings Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 17 days ago - IQVIA Q1 Earnings Call Highlights - MarketBeat
- 20 days ago - Iqvia approves $2B increase to share repurchase authorization - TheFly
- 20 days ago - IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization - Business Wire
- 20 days ago - Iqvia price target lowered to $225 from $240 at Morgan Stanley - TheFly